Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2740-2751
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2740
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2740
General or systemic | Genetic-metabolic causes | Drugs/chemicals |
Obesity | Cystic fibrosis | Ethanol |
Metabolic syndrome | Shwachman syndrome | Ecstasy, cocaine, solvents |
Obstructive sleep apnea | Wilson’s disease | Nifedipine |
Polycystic ovary syndrome | Alpha 1-antitrypsin deficiency | Diltiazem |
Diabetes mellitus type 1 | Fructosemia | Estrogens |
Thyroid disorders | Cholesterol ester storage disease | Corticosteroids |
Hypothalamic-pituitary disorders | Glycogen storage disease (type I, VI and IX) | Methotrexate |
Inflammatory bowel disease | Mitochondrial and peroxisomal defects | Prednisolone |
Celiac disease | α- and β-oxidation defects | Valproate |
Protein calorie malnutrition | Organic acidosis | Vitamin |
Rapid weight loss | Abeta or hypobetalipoproteinemia | Zidovudine and HIV treatments |
Anorexia nervosa | Porphyria cutanea tarda | Solvents |
Small intestinal bacterial overgrowth | Homocystinuria | Pesticides |
Hepatitis C | Familial hyperlipoproteinemias | |
Bile acids synthesis defects | ||
Congenital disorders of glycosylation | ||
Citrin deficiency | ||
Turner syndrome |
- Citation: Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: A stepwise approach. World J Gastroenterol 2013; 19(18): 2740-2751
- URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2740.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2740